Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.
New to MyHealth?
Manage Your Care From Anywhere.
Access your health information from any device with MyHealth. You can message your clinic, view lab results, schedule an appointment, and pay your bill.
ALREADY HAVE AN ACCESS CODE?
DON'T HAVE AN ACCESS CODE?
NEED MORE DETAILS?
MyHealth for Mobile
Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes
Phase 1/1b Safety Study of Prgn-3006 Ultracar-T in Patients with Relapsed or Refractory CD33-Positive Acute Myeloid Leukemia and Higher Risk Myelodysplastic Syndromes Sallman, D. A., Elmariah, H., Sweet, K., Mishra, A., Cox, C. A., Chakaith, M., Semnani, R., Shehzad, S., Anderson, A., Sabzevari, H., Lankford, A., Chan, O., SanchezMolina, L., Wang, C., Padron, E., Kuykendall, A., Komrokji, R. S., Lancet, J. E., Davila, M. L., Bejanyan, N. ELSEVIER. 2022: 10313-10315View details for DOI 10.1182/blood-2022-169142
View details for Web of Science ID 000893230303145